Tag : IFM

Latest News

Novartis in nearly $1.6B deal to buy NASH-focused subsidiary of IFM Therapeutics

The deal includes a $310 million upfront payment plus milestones for three IFM Tre assets – one clinical drug for NASH and atherosclerosis and two...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy